Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer : a randomised, multicentre, placebo-controlled phase II study

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570291224378139776
  • NII Article ID
    20001399162
  • Data Source
    • CiNii Articles

Report a problem

Back to top